Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years
Download the PDF version: EN | DE Lainate, Italy - August 20, 2019 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced...
www.cassiopea.com
Possiamo sperare in una commercializzazione nel 2020?